New pathological and clinical insights in endometrial cancer in view of the updated ESGO/ESTRO/ESP guidelines

A Santoro, G Angelico, A Travaglino, F Inzani… - Cancers, 2021 - mdpi.com
Simple Summary Histopathological classification of endometrial carcinoma has evidenced
two main groups with different biological behavior: low-grade (G1–G2) and high-grade (G3) …

The evolution of ovarian carcinoma subclassification

M Köbel, EY Kang - Cancers, 2022 - mdpi.com
Simple Summary Historically, cancers presenting with their main tumor mass in the ovary
have been classified as ovarian carcinomas (a concise term for epithelial ovarian cancer) …

[HTML][HTML] Genomic landscape of endometrial carcinomas of no specific molecular profile

A Momeni-Boroujeni, B Nguyen, CM Vanderbilt… - Modern Pathology, 2022 - Elsevier
Endometrial carcinomas (ECs) classified by The Cancer Genome Atlas (TCGA) as copy
number-low (also referred to as “no specific molecular profile”[NSMP]) have a prognosis …

Mesonephric-like adenocarcinoma of the female genital tract: from morphologic observations to a well-characterized carcinoma with aggressive clinical behavior

WG McCluggage - Advances in Anatomic Pathology, 2022 - journals.lww.com
Mesonephric-like adenocarcinoma (MLA) was introduced as a new tumor type in the
endometrium and the ovary in the 2020 World Health Organization (WHO) Classification …

[HTML][HTML] Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

R Kudo, A Safonov, C Jones, E Moiso, JR Dry, H Shao… - Cancer cell, 2024 - cell.com
Inhibition of CDK4/6 kinases has led to improved outcomes in breast cancer. Nevertheless,
only a minority of patients experience long-term disease control. Using a large, clinically …

Mesonephric-like adenocarcinoma of the ovary: clinicopathological and molecular characteristics

HH Koh, E Park, HS Kim - Diagnostics, 2022 - mdpi.com
Mesonephric-like adenocarcinoma (MLA) arising in the ovary is a rare malignant tumor of
the female genital tract. Although the clinicopathological and molecular characteristics of …

Mesonephric‐like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like …

J Mirkovic, E Olkhov‐Mitsel, Y Amemiya… - …, 2023 - Wiley Online Library
Aims To report novel observations in five mesonephric‐like adenocarcinomas (MLAs) of the
female genital tract. Methods and results We report two endometrial MLAs in association …

Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?

J Yu, EM da Silva, HS La, BZ Clark, JL Fine… - NPJ Breast …, 2023 - nature.com
This study describes “lobular-like invasive mammary carcinomas”(LLIMCas), a group of low-
to intermediate-grade invasive mammary carcinomas with discohesive, diffusely infiltrative …

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

M Köbel, EY Kang, A Weir, PF Rambau… - The Journal of …, 2023 - Wiley Online Library
Our objective was to test whether p53 expression status is associated with survival for
women diagnosed with the most common ovarian carcinoma histotypes (high‐grade serous …

Mesonephric-like adenocarcinoma of the uterine corpus: Comprehensive immunohistochemical analyses using markers for mesonephric, endometrioid and serous …

H Kim, K Na, GE Bae, HS Kim - Diagnostics, 2021 - mdpi.com
Mesonephric-like adenocarcinoma (MLA) of the uterine corpus is a rare but distinct
malignant tumor of the female genital tract, demonstrating a characteristic morphology and …